(Q39697064)

14 September 2017

title

Pneumococcal meningitis: clinical course and resource use in Western Australian children (English)

1 reference

14 September 2017

1 reference

pneumococcal meningitis

1 reference

King BA

1

1 reference

14 September 2017

Richmond P

series ordinal

2

1 reference

14 September 2017

publication date

1 November 2004

1 reference

Journal of Paediatrics and Child Health

14 September 2017

published in

1 reference

14 September 2017

volume

40

1 reference

14 September 2017

issue

11

1 reference

14 September 2017

page(s)

606-610

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

Pneumococcal meningitis in children: prognostic indicators and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

A study of bacterial meningitis in Kumasi, Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

Meningitis in infancy in England and Wales: follow up at age 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

The emergence of resistant pneumococcal meningitis--implications for empiric therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2004.00485.X

10.1111/J.1440-1754.2004.00485.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference